Abstract
Mammalian receptor-mediated endocytosis (RME) often involves at least one of three isoforms of the large GTPase dynamin (Dyn). Dyn pinches-off vesicles at the plasma membrane and mediates uptake of many viruses, although some viruses directly penetrate the plasma membrane. RME is classically interrogated by genetic and pharmacological interference, but this has been hampered by undesired effects. Here we studied virus entry in conditional genetic knock-out (KO) mouse embryonic fibroblasts lacking expression of all three dynamin isoforms (Dyn-KO-MEFs). The small canine parvovirus known to use a single receptor, transferrin receptor, strictly depended on dynamin. Larger viruses or viruses known to use multiple receptors, including alphaviruses, influenza, vesicular stomatitis, bunya, adeno, vaccinia, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and rhinoviruses infected Dyn-KO-MEFs, albeit at higher dosage than wild-type MEFs. In absence of the transmembrane protease serine subtype 2 (TMPRSS2), which normally activates the SARS-CoV-2 spike protein for plasma membrane fusion, SARS-CoV-2 infected angiotensin-converting enzyme 2 (ACE2)-expressing MEFs predominantly through dynamin- and actin-dependent endocytosis. In presence of TMPRSS2 the ancestral Wuhan-strain bypassed both dynamin-dependent and -independent endocytosis, and was less sensitive to endosome maturation inhibitors than the Omicron B1 and XBB variants, supporting the notion that the Omicron variants do not efficiently use TMPRSS2. Collectively, our study suggests that dynamin function at endocytic pits can be essential for infection with single-receptor viruses, while it is not essential but increases uptake and infection efficiency of multi-receptor viruses that otherwise rely on a functional actin network for infection.
Copyright: © 2024 Ojha et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
MeSH terms
-
Angiotensin-Converting Enzyme 2 / genetics
-
Angiotensin-Converting Enzyme 2 / metabolism
-
Animals
-
Dynamins* / genetics
-
Dynamins* / metabolism
-
Endocytosis* / physiology
-
Fibroblasts / metabolism
-
Fibroblasts / virology
-
Humans
-
Mice
-
Mice, Knockout*
-
SARS-CoV-2 / physiology
-
Virus Internalization*
Substances
-
Dynamins
-
Angiotensin-Converting Enzyme 2
-
Ace2 protein, mouse
Grants and funding
For the funding that supported this research we thank the University of Helsinki Graduate Program in Microbiology and Biotechnology for supporting R.O (2019-2023). The strategic Research Council of Finland grant 335527 (G.B), The Sigrid Juselius Foundation (G.B., 2024-2028
https://www.sigridjuselius.fi/en/), the Faculty of Medicine at the University of Helsinki (G.B.), The Helsinki Institute for Life Sciences at University of Helsinki (2023-2025, G.B.) the Jane and Aatos Erkko Foundation (O.P.V.,
https://jaes.fi/en/frontpage), Helsinki University Hospital funds TYH2021343 (O.P.V.), European Union’s Horizon Europe Research and Innovation Program grant 101057553 (G.B., O.P.V.), The University of Queensland Amplify Fellowship (M.J.), the Australian National Health and Medical Research council (grant 2010917 G.B. and F.A.M.). This work was also supported by Australian Research Council (ARC) Discovery Early Career Researcher Award (DE190100565). The work was supported by an ARC Linkage Infrastructure Equipment and Facilities grant (LE130100078) and a National Health and Medical Research Council (NHMRC) Senior Research Fellowship (GNT1155794) to F.A.M.; P.Y.L is supported by the Agence Nationale de la Recherche (ANR) funding (grant numbers ANR-21-CE11-0012 and ANR-22-CE15-0034). Work in the Greber lab was supported by grants from Schweizerischer Nationalfonds (Swiss National Science Foundation 31003A_179256 and 310030_212802). Y.Y. was supported by ERC Synergy grant CHUbVi (ID: 856581). We are grateful to the Jane and Aatos Erkko Foundation for support to M.V.R. and the Research Council of Finland grant 330896 (to M.V.R.) and 332615 (to E.M.). J.M. was supported by core funding to MRC Laboratory for Molecular Cell Biology at University College London (MC_UU_00012/7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.